Property update — January 2014: break notice
A case mentioned in Wragge & Co’s September/October alert is, unsurprisingly, heading for the appeal court.
The case of Siemens Hearing Instruments Ltd v Friends Life Ltd is due to be heard by the Court of Appeal in late March 2014. As you may recall from the piece in the September-October 2013 alert, the case centres on whether a tenant had served a valid break notice under its lease.
At first instance, the High Court acknowledged that the tenant’s notice did not strictly comply with the requirements laid out in the lease for a valid notice: it failed to state something in the notice that the break clause specifically required. Based on case law to date, the tenant’s notice would therefore have been invalid, and would not have succeeded in bringing the lease to an early end. However, the court went on to find that the tenant had in fact served an effective break notice, despite this…
If you are registered and logged in to the site, click on the link below to read the rest of the Wragge & Co briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
Ruling on an application for specific disclosure could have big implications in the early stages of procurement disputes.
Hospira v Genentech III: Swiss form claim obvious in view of paper reporting the existence of Phase III trial
Arnold J has delivered the latest blow in the ongoing saga surrounding trastuzumab (the monoclonal antibody in Herceptin) and Hospira’s continued efforts to knock out Genentech’s patents.